pharmacie et médicaments – Traitements contre le myélome multiple

This written question concerns access to and pricing of treatments for multiple myeloma, a type of blood cancer. It highlights concerns about the availability and cost of innovative therapies for patients in France. The question seeks information from the government on measures being taken to ensure timely access to these crucial treatments and to manage their economic impact on the healthcare system.